Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Reference Capital (formerly Genevest)

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 55
Average round size
info
The average size of a deal this fund participated in
$9M
Portfolio companies 34
Rounds per year 1.41
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.38
Exits 20
Key employees Soon
Stages of investment
Early Stage Venture
Late Stage Venture
Seed

Areas of investment

  • Health Care
  • Biotechnology
  • Medical
  • Manufacturing
  • Software

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Reference Capital (formerly Genevest):
Typical Co-investors
Reference Capital (formerly Genevest) is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Reference Capital (formerly Genevest):

Funds with similar focus

Funds from Switzerland
Funds with similar focus located in Switzerland:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
8i Ventures India, Maharashtra, Mumbai
Black Angel Tech Fund California, Sacramento, United States
Capaci.Tech Gauteng, Johannesburg, South Africa
CIM Group California, Los Angeles, United States
Colman Partners California, Corte Madera, United States
Formative Ventures California, Santa Clara, United States
InforMax Inc. Bethesda, Maryland, United States
iSmart Ventures -
Ningbo Boshan Guquan Touzi Hehuo Qiye China, Ningbo, Zhejiang
Old Lane LP New York, New York, United States
OPT Chiyoda, Japan
Permal Asset Management New York, New York, United States
Pluralsight Draper, United States, Utah
Servier Canada -
Sino Capital Group China, Hong Kong, Hong Kong Island
Solar Group India, Maharashtra, Nagpur
Tidesquare Seoul, Seoul-t'ukpyolsi, South Korea
ZPLAY -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Wayve

Artificial Intelligence
Autonomous Vehicles
Computer
Electric Vehicle
Machine Learning
Software
$200M17 Jan 2022 London, England, United Kingdom

Kingdom Supercultures

Biotechnology
Food and Beverage
Life Science
Manufacturing
$25M05 Oct 2021 New York, New York, United States

All Day Kitchens

Food and Beverage
Food Delivery
Internet
$65M01 Oct 2021 San Francisco, California, United States

T3 Pharmaceuticals

Biotechnology
Drug Discovery
Life Science
Therapeutics
$27M22 Jul 2020 Basel, Basel-City, Switzerland

Monzo

Banking
Finance
Financial Services
FinTech
Marketplace
$89M16 Jun 2020 London, England, United Kingdom

T3 Pharmaceuticals

Biotechnology
Drug Discovery
Life Science
Therapeutics
$13M26 Sep 2019 Basel, Basel-City, Switzerland

SOPHiA GENETICS

Artificial Intelligence
Big Data
Bioinformatics
Biotechnology
Genetics
Health Care
Life Science
Machine Learning
Medical
$15M16 Dec 2015 Boston, Massachusetts, United States

NovImmune

Biotechnology
Medical
Pharmaceutical
01 Jun 2012 Geneva, Switzerland

Neocutis

Beauty
Biotechnology
Cosmetics
Health Care
Medical
15 Sep 2011 San Francisco, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Reference Capital (formerly Genevest)?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: